Flipkart Reports Record SingleDay Sales of 200 Million Marking Milestone in Indian ECommerce General Motors Reveals AllElectric Cadillac Vistiq with 300Mile Range Intuitive Surgical Stock Lags Broader Market Amid Steep Declines MACOM MTSI and IQE plc Announce LongTerm Supply Agreements for Advanced Semiconductor Materials Campbell Oil Co Expands Reach with Acquisition of Johns Fuel Service Smaller Robotaxi Challenger Posts Nearly 400 Revenue Growth Dwarfing Tesla in Segment PLAY Q1 2026 Earnings Major EPS Miss Clouds Outlook Stock Inches Higher Loop Industries Q1 2026 Earnings Narrowerthanexpected loss amid steady technology development LFT Q1 2026 Earnings EPS Miss Weighs on Market Sentiment AEE Q1 2026 Earnings EPS Beats Estimates as Operational Strength Drives Performance NTR Q1 2026 Earnings EPS Miss Slightly but Stock Gains Amid Mixed Sentiment Janus Living Q1 2026 Earnings EPS Falls Short of Analyst Expectations Clover Health CLOV Slips Below Key Level as Selling Pressure Persists Hercules Capital 625 Notes Due 2033 HCXY Holds Steady Near Support as FixedIncome Market Watches Rate Signals Cronos Group CRON Edges Higher as Cannabis Stock Tests Key Resistance Avidia Bancorp AVBC Holds Steady Near 19 as Support and Resistance Levels Tighten AirSculpt Technologies AIRS Gains 3 as Stock Tests Key Resistance Levels Bakri Id 2026 Indian Stock Markets to Close on May 28 NSE BSE Holiday Schedule Autoliv Inc ALV Q1 2026 Earnings EPS Beat Drives Modest Stock Gain FutureFuel Corp FF Edges Higher Amid Modest Trading Activity HYFM Q3 2025 Earnings Significant EPS Miss Highlights Ongoing Challenges LMND Q1 2026 Earnings Narrowing Losses Beat Expectations as Underwriting Improves GLDG Q1 2026 Earnings Narrowerthanexpected loss as exploration ramp continues UBFO Q4 2025 Earnings Modest Earnings in a Quiet Quarter Embecta Corp EMBC Q1 2026 Earnings EPS Misses Expectations as Revenue Data Remains Unavailable Aqua Metals Q3 2025 Earnings EPS Misses Estimates by Wide Margin Amid Continued Operational Challenges ALXO Q1 2026 Earnings NarrowerthanExpected Loss per Share Mirrors ClinicalStage Focus